Zobrazeno 1 - 10 of 38 pro vyhledávání: '"C, Herink"'
1
Akademický článek
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the 'peer tele-HCV' study
Autor: Megan C. Herink, Andrew Seaman, Gillian Leichtling, Jessica E. Larsen, Tonhi Gailey, Ryan Cook, Ann Thomas, P. Todd Korthuis
Publikováno v: Addiction Science & Clinical Practice, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background Hepatitis C virus (HCV) transmission is primarily driven by injection drug use, and acute HCV infection rates are increased in rural communities with substantial barriers to care. Treatment of HCV in persons who use drugs (PWUD) i
Externí odkaz: https://doaj.org/article/1e53ba4e22694696aa2908208a445a56
Zobrazit plný text záznamu
2
Akademický článek
Launching an innovative educational model addressing substance use disorders and dental pain management (Project ECHO® in dentistry)
Autor: Richie Kohli, Karan Replogle, Andrea Gough-Goldman, Barry Taylor, Brandon Maughan, Harjit Singh Sehgal, Megan C. Herink, Rosemarie Hemmings, Sean Mahoney, Margaret McLain McDonnell, Kenneth McLemore, Eli Schwarz
Publikováno v: BMC Oral Health, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Uninformed opioid prescribing by dentists has contributed to the current opioid crisis. This report describes the development and implementation of an innovative, interactive, multidisciplinary, and participant-centric telementori
Externí odkaz: https://doaj.org/article/d9a16a407fa64306a491c890058cdb7d
Zobrazit plný text záznamu
3
Akademický článek
Pharmacists’ Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation
Autor: Megan C. Herink, Kirbee Johnston, Kristin Breninger, Erin Wu, Adriane N. Irwin
Publikováno v: Pharmacy, Vol 10, Iss 5, p 126 (2022)
The “breakthrough therapy” designation (BTD) is a recent mechanism implemented by the United States Food and Drug Administration (FDA) to expedite access to drugs that address unmet needs. The purpose of this study is to describe pharmacists’ k
Externí odkaz: https://doaj.org/article/b2abf1533abf41538e51420033718df7
Zobrazit plný text záznamu
6
Frequency and clinical outcomes of pharmacist-driven switching from warfarin to direct oral anticoagulants in an underserved patient population: A retrospective cohort study
Autor: Rebekah R Bartholomew, Brie N Noble, Jennifer J Stanislaw, Megan Viehmann, Megan C Herink, Jon P Furuno
Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
Purpose Direct oral anticoagulant (DOAC) medications have improved safety, efficacy, and laboratory monitoring requirements compared to warfarin. However, available data are limited on the frequency and clinical outcomes of pharmacist-driven warfarin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fe4a1171129a64243afb5928bbbb1a
https://pubmed.ncbi.nlm.nih.gov/36525478
Zobrazit plný text záznamu
7
Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model
Autor: Anthony J. McKenzie, Brie N. Noble, Megan C. Herink, Megan M. Viehmann, Jon P. Furuno
Publikováno v: Journal of Pharmacy Practice. :089719002311651
Background Treatment with medications for opioid use disorder (MOUD) may improve hepatitis C virus (HCV) treatment outcomes by providing additional contact with health care professionals to support patient engagement. Objective: We describe a pharmac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d6e8dc11fef650eb90d094f9b15bd40a
https://doi.org/10.1177/08971900231165172
Zobrazit plný text záznamu
9
Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis
Autor: Atif Zaman, Jonah Geddes, Daniel M. Hartung, Kim Vo, Megan C. Herink
Publikováno v: Journal of managed carespecialty pharmacy. 27(7)
BACKGROUND: Although direct-acting antivirals (DAA) have revolutionized the treatment of chronic hepatitis C virus (HCV), many state Medicaid programs have limited coverage because of their expense. In 2015, the Centers for Medicare & Medicaid Servic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0275827dd5d33666c796b652ebf7d4f6
https://pubmed.ncbi.nlm.nih.gov/34185560
Zobrazit plný text záznamu
10
Clinical Management of Pharmacokinetic Drug Interactions with Direct Oral Anticoagulants (DOACs)
Autor: Thomas G. DeLoughery, Craig D. Williams, Megan C. Herink, Yan F. Zhuo
Publikováno v: Drugs. 79:1625-1634
Compared with warfarin, the direct-acting oral anticoagulants (DOAC) have fewer pharmacokinetic drug interactions. However, significant drug interactions do exist with documented changes in DOAC concentrations, which can exceed 100%. Unlike warfarin,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4f8af121df29189e96af3eb4da8bed
https://doi.org/10.1007/s40265-019-01183-0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje